The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Welcome to The Cutaneous T-Cell Lymphoma (CTCL) Channel
VJHemOnc brings you important developments in the field of CTCL presented by esteemed experts from around the world. The CTCL Channel offers exclusive video interviews as well as podcasts and in-depth roundtable discussions so you can keep up with the latest wherever you are.
The CTCL Channel covers all key research areas including insightful views on managing Sézary syndrome, systemic therapies including antibody-drug conjugates, novel clinical trial data, and much more.
